Tara M. Graff
Expertise in
103
conditions

Dr. Tara M. Graff

Hematology Oncology
MercyOne Centerville Specialty Care
One St. Joseph's Drive, 
Centerville, IA 
Accepting New Patients
Offers Telehealth
Expertise in
103
conditions
MercyOne Centerville Specialty Care
One St. Joseph's Drive, 
Centerville, IA 

Overview

Tara Graff, DO, specializes in Hematology/Oncology at Mission Blood + Cancer in Des Moines, Iowa.Medical interests:Dr. Graff has led several clinical research projects and has published many original oncology and hematology articles.Certifications: Internal Medicine; Medical OncologyMedical School: Lake Erie College of Osteopathic Medicine, Bradenton, FL Residency:Medical College of Wisconsin; Froedtert Memorial Lutheran Hospital Fellowship: Medical College of Wisconsin; Froedtert Memorial Lutheran Hospital.

Dr. Graff is highly rated in 103 conditions, according to our data. Her clinical expertise encompasses B-Cell Lymphoma, Non-Hodgkin Lymphoma, Plasmacytoma, Paget Disease of the Breast, and Bone Marrow Aspiration.

She is actively involved in clinical research, co-authoring 8 peer reviewed articles and participating in 2 clinical trials. Dr. Graff is currently accepting new patients.

Specialties

Hematology Oncology

Licenses

Internal Medicine in IA

Hospital Affiliations

Mercyone Centerville Medical Center
University Of Iowa Hospital & Clinics
Unitypoint Health - Des Moines Iowa Methodist Medi
Mercyone Des Moines Medical Center
Davis County Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Farm Bureau Health Plans
  • HMO
  • MEDICARE MAPD
  • MEDICARE PDP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
SelectHealth
  • HMO
  • POS
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Wellmark
  • HMO
  • POS
View 16 Less Insurance Carriers -

Locations

MercyOne Centerville Specialty Care
One St. Joseph's Drive, Centerville, IA 52544
Other Locations
Mission Blood + Cancer
411 Laurel St., Suite A300, Des Moines, IA 50314

Additional Areas of Focus

Dr. Graff has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Phase 1/2 Study of Selinexor in Combination With Backbone Treatments or Novel Therapies in Patients With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)
A Multicenter, Phase 1/2 Study of Selinexor in Combination With Backbone Treatments or Novel Therapies in Patients With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)
Enrollment Status: Withdrawn
Publish Date: October 03, 2025
Intervention Type: Drug
Study Drugs: Selinexor, Rituximab, Bendamustine, Polatuzumab Vedotin, Ibrutinib, Lenalidomide, Tafasitamab, Venetoclax, Gemcitabine, Oxaliplatin
Study Phase: Phase 1/Phase 2
A Phase 2 Trial of the Combination of Polatuzumab Vedotin, Venetoclax and Rituximab and Hyaluronidase Human for Relapsed and Refractory Mantle Cell Lymphoma
A Phase 2 Trial of the Combination of Polatuzumab Vedotin, Venetoclax and Rituximab and Hyaluronidase Human for Relapsed and Refractory Mantle Cell Lymphoma
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Biological, Drug
Study Drugs: Polatuzumab Vedotin, Rituximab, Hyaluronidase Human, Venetoclax
Study Phase: Phase 2
View 1 Less Clinical Trial

8 Total Publications

Treating large B-cell lymphoma: Current strategies and unmet needs across community and academic settings.
Treating large B-cell lymphoma: Current strategies and unmet needs across community and academic settings.
Journal: Blood reviews
Published: March 30, 2026
Similar Doctors
Expertise in
88
conditions
Dr. Angela E. Sandre
Hematology Oncology
Expertise in
88
conditions
Dr. Angela E. Sandre
Hematology Oncology
Referral may be required

MercyOne Centerville Specialty Care

One St. Joseph's Drive, 
Centerville, IA 
 (0.1 miles away)
641-437-3482
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Angela Sandre, DO is a medical oncology and hematology physician with Mission Cancer + Blood. Dr. Sandre earned her medical degree from Des Moines University. Dr. Sandre completed both her internship and residency at the University of Iowa, Des Moines Internal Medicine Residency. Following residency, Dr. Sandre completed a fellowship at the Huntsman Cancer Institute at the University of Utah in Salt Lake City. Dr. Sandre is highly rated in 88 conditions, according to our data. Her clinical expertise encompasses B-Cell Lymphoma, Paget Disease of the Breast, Non-Hodgkin Lymphoma, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Sandre is currently accepting new patients.

Expertise in
0
conditions
Dr. Kristi L. Van Leeuwen
Hematology Oncology
Expertise in
0
conditions
Dr. Kristi L. Van Leeuwen
Hematology Oncology
Referral may be required

MercyOne Centerville Specialty Care

One St. Joseph's Drive, 
Centerville, IA 
 (0.1 miles away)
641-437-3482
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kristi Van Leeuwen, ARNP, specializes in Hematology/Oncology at Mission Blood + Cancer in Des Moines, Iowa and Centerville, Iowa. Her clinical expertise encompasses Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Paget Disease of the Breast, and Breast Cancer. Dr. Van Leeuwen is currently accepting new patients.

Frequently Asked Questions about Dr. Tara M. Graff

How do I make an appointment with Dr. Tara M. Graff?

You can book an appointment with Dr. Tara M. Graff by calling their office at 641-437-3482. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Tara M. Graff a top-rated expert for B-Cell Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Tara M. Graff is classified as an Distinguished expert for B-Cell Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Tara M. Graff specialize in?

While Dr. Tara M. Graff is a Hematology Oncology, they have specific expertise in B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Plasmacytoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.

Does Dr. Tara M. Graff participate in research or clinical trials?

Yes. Dr. Tara M. Graff has published 8 articles and abstracts on conditions like B-Cell Lymphoma. You can view a list of Dr. Tara M. Graff's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Tara M. Graff accept my insurance?

Dr. Tara M. Graff accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 641-437-3482 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Graff's expertise for a condition
ConditionClose
    View All 25 Distinguished Conditions
    View All 78 Advanced Conditions
    View All 164 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile